Stock METROPOLIS METROPOLIS HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Metropolis Healthcare Limited

Equities

METROPOLIS

INE112L01020

Healthcare Facilities & Services

End-of-day quote NSE India S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
1,838 INR -1.59% Intraday chart for Metropolis Healthcare Limited +5.17% +9.54%
May. 10 India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand RE
Apr. 11 Metropolis Healthcare Books 10% Increase in Fiscal Q4 Overall Revenue MT

Valuation

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 65,032 114,563 104,174 63,926 94,169 - -
Enterprise Value (EV) 1 62,802 110,283 104,952 63,654 93,093 91,904 90,285
P/E ratio 50.9 x 62.6 x 48.9 x 44.9 x 69.7 x 51.4 x 41.5 x
Yield 0.62% 0.36% 0.39% 0.64% 0.53% 0.7% 0.86%
Capitalization / Revenue 7.59 x 11.5 x 8.48 x 5.57 x 7.92 x 6.94 x 6.17 x
EV / Revenue 7.33 x 11.1 x 8.54 x 5.54 x 7.83 x 6.78 x 5.92 x
EV / EBITDA 27 x 38.6 x 30.6 x 22.1 x 32.9 x 26.6 x 22.4 x
EV / FCF 33.8 x 49.9 x 47.1 x 32.7 x 53.2 x 38.7 x 31.1 x
FCF Yield 2.96% 2% 2.12% 3.05% 1.88% 2.58% 3.22%
Price to Book 12.4 x 16.2 x 11.8 x 6.47 x 8.78 x 7.93 x 7.09 x
Nbr of stocks (in thousands) 50,631 51,117 51,172 51,211 51,229 - -
Reference price 2 1,284 2,241 2,036 1,248 1,838 1,838 1,838
Announcement Date 5/29/20 5/27/21 5/24/22 5/16/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 7,694 8,564 9,980 12,283 11,482 11,893 13,560 15,259
EBITDA 1 2,086 2,328 2,860 3,428 2,883 2,831 3,452 4,035
EBIT 1 - 1,685 2,401 2,796 1,991 1,929 2,448 2,984
Operating Margin - 19.68% 24.05% 22.76% 17.34% 16.22% 18.06% 19.55%
Earnings before Tax (EBT) 1 - 1,687 2,443 2,934 1,875 1,804 2,444 3,049
Net income 1 - 1,273 1,831 2,142 1,429 1,335 1,824 2,279
Net margin - 14.87% 18.35% 17.44% 12.44% 11.23% 13.45% 14.93%
EPS 2 24.02 25.25 35.79 41.66 27.81 26.38 35.75 44.32
Free Cash Flow 1 - 1,858 2,208 2,226 1,945 1,749 2,373 2,907
FCF margin - 21.7% 22.13% 18.12% 16.94% 14.7% 17.5% 19.05%
FCF Conversion (EBITDA) - 79.81% 77.22% 64.94% 67.45% 61.77% 68.76% 72.05%
FCF Conversion (Net income) - 145.94% 120.62% 103.94% 136.1% 130.95% 130.09% 127.6%
Dividend per Share 2 13.26 8.000 8.000 8.000 8.000 9.753 12.89 15.74
Announcement Date 5/13/19 5/29/20 5/27/21 5/24/22 5/16/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,748 2,917 3,268 3,026 2,931 3,059 2,799 3,003 2,855 2,825 2,771 3,059 2,932 3,048 3,106
EBITDA 1 866.4 963.9 1,024 902.4 753.3 748.5 684.9 790.3 704.9 702.9 629.4 769.6 709.6 749.9 -
EBIT 1 756.7 823.1 890.6 752 584.4 568.6 473.2 574.5 474.6 468.5 421.2 545.2 489.9 509.2 554.2
Operating Margin 27.54% 28.21% 27.26% 24.85% 19.94% 18.59% 16.91% 19.13% 16.63% 16.58% 15.2% 17.82% 16.71% 16.71% 17.85%
Earnings before Tax (EBT) 1 777.7 816.5 1,031 777.1 560.9 564.7 428.3 548 479.7 - 391.9 511.3 451.5 510.2 -
Net income 1 585.7 613.5 748.9 582.7 410.4 399.9 334 403.3 358 333.6 289.8 390.8 336.4 382.6 -
Net margin 21.32% 21.03% 22.92% 19.25% 14% 13.07% 11.93% 13.43% 12.54% 11.81% 10.46% 12.78% 11.47% 12.55% -
EPS 2 11.46 11.99 14.58 11.34 7.980 7.780 6.490 7.850 6.970 6.490 5.610 7.592 6.872 7.207 8.230
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/10/21 5/27/21 8/6/21 11/10/21 2/11/22 5/24/22 8/10/22 11/8/22 2/10/23 5/16/23 8/2/23 - - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 779 - - - -
Net Cash position 1 - 2,230 4,280 - 272 1,076 2,265 3,884
Leverage (Debt/EBITDA) - - - 0.2271 x - - - -
Free Cash Flow 1 - 1,858 2,208 2,226 1,945 1,749 2,373 2,907
ROE (net income / shareholders' equity) - 31% 29.8% 26.9% 15.2% 12.8% 16.2% 18.2%
ROA (Net income/ Total Assets) - - 20.8% 16.9% 9.43% - - -
Assets 1 - - 8,783 12,674 15,160 - - -
Book Value Per Share 2 - 103.0 138.0 173.0 193.0 209.0 232.0 259.0
Cash Flow per Share 2 18.00 - 48.70 49.30 48.10 45.60 59.70 66.60
Capex 1 196 292 282 307 526 498 525 461
Capex / Sales 2.54% 3.41% 2.82% 2.5% 4.58% 4.18% 3.87% 3.02%
Announcement Date 5/13/19 5/29/20 5/27/21 5/24/22 5/16/23 - - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Metropolis Healthcare Limited

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
1,838 INR
Average target price
1,733 INR
Spread / Average Target
-5.74%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+9.54% 1.13B
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-16.99% 8.55B
RADNET, INC. Stock RadNet, Inc.
+65.23% 4.24B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-1.63% 2.54B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-41.76% 2.35B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-8.53% 1.89B
FLEURY S.A. Stock Fleury S.A.
-19.29% 1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-39.61% 1.23B
VIJAYA DIAGNOSTIC CENTRE LIMITED Stock Vijaya Diagnostic Centre Limited
+19.57% 955M
H.U. GROUP HOLDINGS, INC. Stock H.U. Group Holdings, Inc.
-5.12% 924M
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. METROPOLIS Stock
  4. Financials Metropolis Healthcare Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW